Identifying early signs of serious eye complications in diabetic patients
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy
This study is looking at new imaging technology to help doctors spot serious eye problems in people with diabetic retinopathy earlier and more accurately, so they can provide better care for those at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11061279 on NIH RePORTER |
What this research studies
This research focuses on improving the detection of vision-threatening complications in diabetic retinopathy (DR) using advanced imaging technology called optical coherence tomography angiography (OCTA). By identifying specific precursors to serious conditions like proliferative diabetic retinopathy and diabetic macular edema, the study aims to enhance the precision of risk assessment compared to traditional methods. The approach involves developing automated systems for better identification and segmentation of these biomarkers, making it easier for clinicians to diagnose and treat at-risk patients effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are at risk for developing diabetic retinopathy or its complications.
Not a fit: Patients who do not have diabetes or those who are not at risk for diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate identification of patients at risk for severe vision loss, allowing for timely intervention.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for identifying risks in diabetic retinopathy, suggesting that this approach could be effective.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Jia, Yali — Oregon Health & Science University
- Study coordinator: Jia, Yali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.